FINWIRES · TerminalLIVE
FINWIRES

道明银行表示,加拿大各省今年的预算有所增加,但仍低于历史水平。

By

-- 道明银行(TD)表示,加拿大今年各省公布的预算案显示,2026/27财年的总赤字约为国内生产总值(GDP)的1.4%,较去年有所恶化,但按历史标准衡量仍属温和。 道明银行在致客户的报告中指出,各省的净债务占GDP的比率预计将进一步攀升。 道明银行指出,近期能源价格上涨已使短期财政风险向预算状况改善的方向倾斜,尤其是对于大宗商品生产省份而言。 道明银行表示,资本支出仍然是财政计划的核心支柱,为短期经济增长提供支撑,但同时也加剧了大多数地区的中期债务和偿债压力。 道明银行补充道,新的政策举措被刻意限制,重点放在可负担性、住房和核心服务上。在一定程度上,有针对性的支持将有助于提振国内经济活动,从而可能抵消外部冲击对实际增长的下行风险。 世界银行指出,本季度各省的预算反映出财政空间趋紧,大多数省政府选择采取渐进式、有针对性的措施,而非大规模的新支出。预计未来几年赤字仍将持续存在,尽管油价冲击使大宗商品省份的财政状况有所改善,但同时也使能源进口省份的前景更加复杂,因为持续的赤字和高企的债务负担使得这些省份的财政状况更容易受到负面经济冲击的影响。

Related Articles

Research

Morgan Stanley Downgrades AES to Equalweight From Overweight, Adjusts Price Target to $15 From $23

AES (AES) has an average rating of hold and mean price target of $15.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$AES
Australia

Compass Therapeutics Tovecimig Study Falls Short on Overall Survival Endpoint in Biliary Tract Cancer; Shares Fall Pre-Bell

Compass Therapeutics (CMPX) reported that its experimental drug tovecimig did not meet the overall survival secondary endpoint in a phase 2/3 study in patients with advanced biliary tract cancer, the company said Monday.Shares of the company fell more than 63% in recent pre-bell activity Monday.The company said that tovecimig plus paclitaxel did not show a statistically significant overall survival benefit versus chemotherapy alone, largely due to high crossover from the control arm and prolonged survival after switching to the drug.However, the study met other key endpoints, including statistically significant improvements in progression-free survival and overall response rate versus paclitaxel alone.Compass Therapeutics plans to meet with the US Food and Drug Administration to discuss the results ahead of a planned biologics license application submission, it added.Price: $1.91, Change: $-3.11, Percent Change: -63.35%

$CMPX
Sectors

Gold Eases Early Even as the Dollar Falls Ahead of This Week's U.S. Interest Rate Decision

Gold prices eased early on Monday, remaining rangebound even as the dollar fell ahead of the Wednesday interest-rate announcement from the Federal Reserve.Gold for June delivery was last seen down US$26.50 to US$4,714.40 per ounce, remaining within the US$200 range it has been stuck in since the start of the war on Iran, as high oil prices raise concerns over higher inflation and threaten to boost interest rates.The Federal Open Market Committee (FOMC) will make its latest interest-rate decision at the Wednesday afternoon end to its two-day meeting. The CME FedWatch Tool sees a 100% probability the group will leave rates unchanged."Gold remains stuck in neutral within a broad USD 200 range around USD 4,750, with most intraday price action dictated by energy prices and the ebb and flow of headlines from the White House and the Middle East. The FOMC is widely expected to leave rates unchanged on Wednesday," Saxo Bank noted.The dollar was lower early, with the ICE dollar index last seen down 0.28 points to 98.26. Treasury yields rose, with the yield on the two-year note up 1.0 basis points to 3.801%, while the 10-year note was paying 4.321%, up 1.3 points.

$GCM6$GLD